AI Image
Doctor reveals 6 rebound risks GLP-1 users face after stopping
New York Post • • health
Key Points:
- Many patients discontinue GLP-1 medications like Ozempic, Wegovy, and Zepbound within a year due to side effects such as nausea and digestive issues, or a preference to avoid long-term medication use.
- Stopping GLP-1 drugs often leads to rapid return of hunger, weight regain, worsening biomarkers like blood sugar and cholesterol, and potential loss of cardiovascular protection, increasing risks of heart attacks and strokes.
- Weight loss from GLP-1s includes both fat and muscle mass, and patients who regain weight after stopping may not fully recover lost muscle, potentially impairing metabolism and physical function.
- Discontinuation can also negatively impact mental health, as patients may feel disheartened by weight regain and loss of control after seeing GLP-1s as a final solution.
- To maintain progress after stopping GLP-1s, patients should achieve metabolic goals through sustainable lifestyle and dietary changes, ideally under medical supervision to monitor weight and blood sugar levels.
